Page last updated: 2024-08-22

clodronic acid and Leukemia, Myelomonocytic, Chronic

clodronic acid has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aixinjueluo, W; Arai, S; Honda, A; Hosoi, M; Kataoka, K; Kobayashi, T; Kumano, K; Kurokawa, M; Miyauchi, M; Nakahata, T; Nakauchi, H; Niwa, A; Otsu, M; Taoka, K; Yamazaki, S; Yoshimi, A1

Other Studies

1 other study(ies) available for clodronic acid and Leukemia, Myelomonocytic, Chronic

ArticleYear
Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate.
    Scientific reports, 2018, 10-26, Volume: 8, Issue:1

    Topics: Aged; Animals; Cell Differentiation; Clodronic Acid; Disease Models, Animal; Drug Repositioning; Enhancer of Zeste Homolog 2 Protein; Hematopoietic Stem Cells; Humans; Induced Pluripotent Stem Cells; Leukemia, Myelomonocytic, Chronic; Liposomes; Male; Mice; Neurofibromin 1; Phosphorylation; Protein Kinase Inhibitors; STAT5 Transcription Factor; Teratoma; Transplantation, Heterologous

2018